<table-wrap id="T2" position="float"> 
 <label>Table 2</label>  
 <p>Novel RASSF1C target genes in T47D breast cancer cells</p>  
 <table frame="hsides" rules="groups"> 
  <thead> 
   <tr> 
    <th align="left">Gene</th>
    <th align="left">Gene discription</th>
    <th align="left">Fold change</th> 
   </tr> 
  </thead> 
  <tbody> 
   <tr> 
    <td align="left">EFEM1</td>
    <td align="left">EGF-containing fibulin-like extracellular matrix protein 1</td>
    <td align="right">5.76</td> 
   </tr> 
   <tr> 
    <td align="left">GHR</td>
    <td align="left">growth hormone receptor</td>
    <td align="right">4.3</td> 
   </tr> 
   <tr> 
    <td align="left">EGR1</td>
    <td align="left">early growth response 1</td>
    <td align="right">5.9</td> 
   </tr> 
   <tr> 
    <td align="left">TP53IN1</td>
    <td align="left">tumor protein p53 inducible nuclear protein 1</td>
    <td align="right">4.46</td> 
   </tr> 
   <tr> 
    <td align="left">MRAS</td>
    <td align="left">muscle RAS oncogene homolog</td>
    <td align="right">3.8</td> 
   </tr> 
   <tr> 
    <td align="left">MTUS1</td>
    <td align="left">mitochondrial tumor suppressor 1</td>
    <td align="right">-2</td> 
   </tr> 
   <tr> 
    <td align="left">PROS</td>
    <td align="left">protein S (alpha)</td>
    <td align="right">4</td> 
   </tr> 
   <tr> 
    <td align="left">EMP1</td>
    <td align="left">epithelial membrane protein 1</td>
    <td align="right">-7.5</td> 
   </tr> 
   <tr> 
    <td align="left">HOXA1</td>
    <td align="left">homeobox A1</td>
    <td align="right">4.6</td> 
   </tr> 
   <tr> 
    <td align="left">SEPP1</td>
    <td align="left">selenoprotein P, plasma, 1</td>
    <td align="right">7.92</td> 
   </tr> 
   <tr> 
    <td align="left">MGMT</td>
    <td align="left">O-6-methylguanine-DNA methyltransferase</td>
    <td align="right">2.1</td> 
   </tr> 
   <tr> 
    <td align="left">PAK1</td>
    <td align="left">p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)</td>
    <td align="right">2.1</td> 
   </tr> 
   <tr> 
    <td align="left">CXCR4</td>
    <td align="left">chemokine (C-X-C motif) receptor 4</td>
    <td align="right">3.6</td> 
   </tr> 
   <tr> 
    <td align="left">CREG</td>
    <td align="left">cellular repressor of E1A-stimulated genes 1</td>
    <td align="right">11.2</td> 
   </tr> 
   <tr> 
    <td align="left">BMPR2</td>
    <td align="left">bone morphogenetic protein receptor, type II (serine/threonine kinase)</td>
    <td align="right">2</td> 
   </tr> 
   <tr> 
    <td align="left">Noggin</td>
    <td align="left">Noggin</td>
    <td align="right">-3.6</td> 
   </tr> 
   <tr> 
    <td align="left">SSP1</td>
    <td align="left">(osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)</td>
    <td align="right">-14.5</td> 
   </tr> 
   <tr> 
    <td align="left">TGM2</td>
    <td align="left">TGM2: transglutaminase 2 (protein-glutamine-gamma-glutamyltransferase)</td>
    <td align="right">3</td> 
   </tr> 
   <tr> 
    <td align="left">SRPX</td>
    <td align="left">sushi-repeat-containing protein, X-linked</td>
    <td align="right">-7.25</td> 
   </tr> 
   <tr> 
    <td align="left">SAMD5</td>
    <td align="left">sterile alpha motif domain containing 5</td>
    <td align="right">-11.47</td> 
   </tr> 
   <tr> 
    <td align="left">MAP1B</td>
    <td align="left">microtubule-associated protein 1B</td>
    <td align="right">-11.7</td> 
   </tr> 
   <tr> 
    <td align="left">RNF182</td>
    <td align="left">ring finger protein 182</td>
    <td align="right">-13.8</td> 
   </tr> 
   <tr> 
    <td align="left">TMEM8</td>
    <td align="left">transmembrane protein 158</td>
    <td align="right">-11.29</td> 
   </tr> 
   <tr> 
    <td align="left">LDB2</td>
    <td align="left">LIM domain binding 2</td>
    <td align="right">-5.85</td> 
   </tr> 
   <tr> 
    <td align="left">IGFBP3</td>
    <td align="left">insulin-like growth factor binding protein 3</td>
    <td align="right">-4.96</td> 
   </tr> 
   <tr> 
    <td align="left">COL131</td>
    <td align="left">collagen, type XIII, alpha 1</td>
    <td align="right">-8.69</td> 
   </tr> 
   <tr> 
    <td align="left">FRMDB</td>
    <td align="left">FERM domain containing 4B</td>
    <td align="right">-5.2</td> 
   </tr> 
   <tr> 
    <td align="left">SOX9</td>
    <td align="left">SRY (sex determining region Y)-box 9</td>
    <td align="right">-4.5</td> 
   </tr> 
   <tr> 
    <td align="left">DAB2</td>
    <td align="left">disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)</td>
    <td align="right">-2.55</td> 
   </tr> 
   <tr> 
    <td align="left">APOE</td>
    <td align="left">apolipoprotein E</td>
    <td align="right">3.74</td> 
   </tr> 
   <tr> 
    <td align="left">CCND2</td>
    <td align="left">cyclin D2</td>
    <td align="right">-3</td> 
   </tr> 
   <tr> 
    <td align="left">SPANX1</td>
    <td align="left">sperm protein associated with the nucleus, X-linked, family member A1</td>
    <td align="right">7.38</td> 
   </tr> 
   <tr> 
    <td align="left">SPANX1</td>
    <td align="left">SPANX family, member B1</td>
    <td align="right">17.7</td> 
   </tr> 
   <tr> 
    <td align="left">HLADP1</td>
    <td align="left">major histocompatibility complex, class II, DP alpha 1</td>
    <td align="right">12.7</td> 
   </tr> 
   <tr> 
    <td align="left">HIST1H2BC</td>
    <td align="left">histone cluster 1 H2BC</td>
    <td align="right">5.34</td> 
   </tr> 
   <tr> 
    <td align="left">DACH1</td>
    <td align="left">dachshund homolog 1 (Drosophila)</td>
    <td align="right">7.63</td> 
   </tr> 
   <tr> 
    <td align="left">PCDH7</td>
    <td align="left">protocadherin 7</td>
    <td align="right">8.58</td> 
   </tr> 
   <tr> 
    <td align="left">MYL9</td>
    <td align="left">myosin, light chain 9, regulatory</td>
    <td align="right">9</td> 
   </tr> 
   <tr> 
    <td align="left">DPEP3</td>
    <td align="left">dipeptidase 3</td>
    <td align="right">10.66</td> 
   </tr> 
   <tr> 
    <td align="left">CPE</td>
    <td align="left">carboxypeptidase E</td>
    <td align="right">11.47</td> 
   </tr> 
   <tr> 
    <td align="left">LITAF</td>
    <td align="left">lipopolysaccharide-induced TNF facto</td>
    <td align="right">8.17</td> 
   </tr> 
   <tr> 
    <td align="left">ABAT</td>
    <td align="left">4-aminobutyrate aminotransferase</td>
    <td align="right">10.82</td> 
   </tr> 
  </tbody> 
 </table> 
 <table-wrap-foot> 
  <p>List of novel RASSF1C target genes identified in T47D breast cancer cells using microarray analysis. Affymetrix-microarray analysis was performed using T47D cells over-expressing RASSF1C as outlined in Materials and Methods section. Data analysis was performed using the dChip program [
   <xref ref-type="bibr" rid="B21">
    21
   </xref>] and the thresholds for selecting significant genes were set at a relative difference &gt; = 1.5-fold (or/and 2-fold), absolute signal difference &gt; = 50, and p &lt; 0.05. Genes that met all three criteria were considered as significant changes. Comparison results with False Discovery Rate (FDR) &lt;5% was considered as a valid analysis.</p> 
 </table-wrap-foot> 
</table-wrap>